Effect of a cellulose-containing weight-loss supplement on gastric emptying and sensory functions

Obesity

Volumn 16, Issue 10, 2008, Pages 2272-2280

  Berthold, Heiner K ^a   Unverdorben, Susanne ^a   Degenhardt, Ralf ^a   Unverdorben, Martin ^a   Gouni Berthold, Ioanna ^b  

^a Center for Cardiovascular Diseases   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; CELLULOSE;

ADULT; AGED; APPETITE; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MICROCAPSULE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SATIETY; STOMACH EMPTYING; TIME; TREATMENT OUTCOME;

ADULT; AGED; APPETITE; APPETITE DEPRESSANTS; BLOOD GLUCOSE; BREATH TESTS; CAPSULES; CELLULOSE; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GASTRIC EMPTYING; HUMANS; MALE; MIDDLE AGED; OBESITY; POSTPRANDIAL PERIOD; QUESTIONNAIRES; SATIATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 53849144969     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.355     Document Type: Article

References (50)

1. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
2. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii,1-253.
3. Klein S, Wadden T, Sugerman HJ. AGA technical review on obesity. Gastroenterology 2002;123:882-932.
4. Katz DL, O'Connell M, Yeh MC et al. Public health strategies for preventing and controlling overweight and obesity in school and worksite settings: a report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep 2005;54:1-12.
5. Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007;369:71-77.
6. Greenway FL, Caruso MK. Safety of obesity drugs. Expert Opin Drug Saf 2005;4:1083-1095.
7. Li Z, Maglione M, Tu W et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005;142:532-546.
8. Padwal R, Li SK, Lau DC. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev 2004;CD004094.
9. Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ 2007;335:1194-1199.
10. Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 2007;370:1706-1713.
11. Krakamp B, Diefenbach G, Müller-Wieland D. Adipositastherapie - Plazebokontrollierte Doppelblindstudie zur Wirksamkeit von CM3. Kassenarzt 2001;11:45-47.
12. Ghoos YF, Maes BD, Geypens BJ et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993;104:1640-1647.
13. Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000;24:38-48.
14. Parker BA, Sturm K, MacIntosh CG et al. Relation between food intake and visual analogue scale ratings of appetite and other sensations in healthy older and young subjects. Eur J Clin Nutr 2004;58:212-218.
15. Stubbs RJ, Hughes DA, Johnstone AM et al. The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br J Nutr 2000;84:405-415.
16. Clark SB, Holt PR. Inhibition of steady-state intestinal absorption of long-chain triglyceride by medium-chain triglyceride in the unanesthetized rat. J Clin Invest 1969;48:2235-2243.
17. Evenepoel P, Geypens B, Luypaerts A et al. Digestibility of cooked and raw egg protein in humans as assessed by stable isotope techniques. J Nutr 1998;128:1716-1722.
18. Jackson SJ, Bluck LJ. Measurement of gastric emptying by octanoate metabolism. Curr Opin Clin Nutr Metab Care 2005;8:538-544.
19. Sanaka M, Yamamoto T, Ishii T, Kuyama Y. The Wagner-Nelson method can generate an accurate gastric emptying flow curve from CO2 data obtained by a 13C-labeled substrate breath test. Digestion 2004;69:71-78.
20. Elashoff JD, Reedy TJ, Meyer JH. Analysis of gastric emptying data. Gastroenterology 1982;83:1306-1312.
21. Siegel JA, Urbain JL, Adler LP et al. Biphasic nature of gastric emptying. Gut 1988;29:85-89.
22. Sanaka M, Anjiki H, Tsutsumi H et al. Effect of cigarette smoking on gastric emptying of solids in Japanese smokers: a crossover study using the 13C-octanoic acid breath test. J Gastroenterol 2005;40:578-582.
23. Avenell A, Broom J, Brown TJ et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004;8:iii-iv,1-182.
24. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-1209.
25. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992;16:397-415.
26. Park MI, Camilleri M. Gastric motor and sensory functions in obesity. Obes Res 2005;13:491-500.
27. Wright RA, Krinsky S, Fleeman C, Trujillo J, Teague E. Gastric emptying and obesity. Gastroenterology 1983;84:747-751.
28. Tosetti C, Corinaldesi R, Stanghellini V et al. Gastric emptying of solids in morbid obesity. Int J Obes Relat Metab Disord 1996;20:200-205.
29. French SJ, Murray B, Rumsey RD, Sepple CP, Read NW. Preliminary studies on the gastrointestinal responses to fatty meals in obese people. Int J Obes Relat Metab Disord 1993;17:295-300.
30. Verdich C, Madsen JL, Toubro S et al. Effect of obesity and major weight reduction on gastric emptying. Int J Obes Relat Metab Disord 2000;24:899-905.
31. Maddox A, Horowitz M, Wishart J, Collins P. Gastric and oesophageal emptying in obesity. Scand J Gastroenterol 1989;24:593-598.
32. Jackson SJ, Leahy FE, McGowan AA et al. Delayed gastric emptying in the obese: an assessment using the non-invasive (13)C-octanoic acid breath test. Diabetes Obes Metab 2004;6:264-270.
33. Delgado-Aros S, Camilleri M, Castillo EJ et al. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study. Clin Gastroenterol Hepatol 2005;3:997-1006.
34. Cremonini F, Mullan BP, Camilleri M, Burton DD, Rank MR. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther 2002;16:1781-1790.
35. Choi MG, Camilleri M, Burton DD et al. [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology 1997;112:1155-1162.
36. Marlett JA, McBurney MI, Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc 2002;102:993-1000.
37. Krauss RM, Eckel RH, Howard B et al. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000;102:2284-2299.
38. Howarth NC, Saltzman E, Roberts SB. Dietary fiber and weight regulation. Nutr Rev 2001;59:129-139.
39. Rigaud D, Ryttig KR, Leeds AR, Bard D, Apfelbaum M. Effects of a moderate dietary fibre supplement on hunger rating, energy input and faecal energy output in young, healthy volunteers. A randomized, double-blind, cross-over trial. Int J Obes 1987;11(Suppl 1):73-78.
40. Rigaud D, Ryttig KR, Angel LA, Apfelbaum M. Overweight treated with energy restriction and a dietary fibre supplement: a 6-month randomized, double-blind, placebo-controlled trial. Int J Obes 1990;14:763-769.
41. Howarth NC, Saltzman E, McCrory MA et al. Fermentable and nonfermentable fiber supplements did not alter hunger, satiety or body weight in a pilot study of men and women consuming self-selected diets. J Nutr 2003;133:3141-3144.
42. Salas-Salvado J, Farres X, Luque X et al. Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial. Br J Nutr 2008;99:1380-1387.
43. Deutsch JA, Young WG, Kalogeris TJ. The stomach signals satiety. Science 1978;201:165-167.
44. Granstrom L, Backman L. Stomach distension in extremely obese and in normal subjects. Acta Chir Scand 1985;151:367-370.
45. Galmiche JP, Delbende B, Perri F, Andriulli A. 13C octanoic acid breath test. Gut 1998;43(Suppl 3):S28-S30.
46. Sanaka M, Nakada K, Nosaka C, Kuyama Y. The Wagner-Nelson method makes the [13C]-breath test comparable to radioscintigraphy in measuring gastric emptying of a solid/liquid mixed meal in humans. Clin Exp Pharmacol Physiol 2007;34:641-644.
47. Lee JS, Camilleri M, Zinsmeister AR et al. Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test. Am J Gastroenterol 2000;95:2751-2761.
48. Choi MG, Camilleri M, Burton DD et al. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 1998;93:92-98.
49. Conze J, Krones CJ, Prescher A, Schumpelick V. Partial intestinal obstruction after swallowing a self-expanding sponge for weight reduction [Partielle intestinale Obstruktion durch selbstexpandierendes Schwämmchen als Schlankheitsmittel]. Dtsch Med Wochenschr 2003;128:1706-1708.
50. Federal Institute for Drugs and Medical Devices (BfArM). Adverse effects of CM3 [Nebenwirkungen von CM3]. Press release 18/01 of 27 September, Bonn, Germany 〈http://www.bfarm.de/cln_029/nn_1043408/DE/Presse/mitteil2001/pm18- 2001.html〉 (2001).